Company News
- Why Did Board Insiders Recently Buy More Than 500,000 Shares of This Company's Stock?
Sep 17, 2019, 11:30 AM EDT - CTD Holdings Announces FDA Approval of US Expanded Access Treatment Program in Niemann-Pick Disease Type C
Sep 13, 2019, 8:00 AM EDT - CTD Holdings to Present at 2019 Annual Conference for NPC Patients, Families, and Health Professionals in the United Kingdom
Sep 11, 2019, 8:07 AM EDT - CTD Holdings Interview to Air on Bloomberg International on the RedChip Money Report
Sep 4, 2019, 11:46 AM EDT - CTD Holdings Holds Shareholders’ Meeting: All Proposals are Approved
Aug 27, 2019, 11:14 AM EDT - CTD Announces New Data Presented at Annual Gathering of Patients and Families Tackling Niemann-Pick Disease Type C
Aug 15, 2019, 8:00 AM EDT - CTD Holdings Announces Filing of Data From Expanded Access Program in Late Onset Alzheimer’s Disease in Support of Its Patent Application Filed In 2018
Aug 13, 2019, 8:00 AM EDT - CTD Announces Support and Participation at Annual Family Conference of National Niemann-Pick Disease Foundation
Jul 31, 2019, 9:28 AM EDT - CTD Holdings Scientific Advisory Board Endorses Alzheimer’s Disease as Next Indication for Company’s Trappsol® Cyclo™ Drug Development Program
Jul 18, 2019, 10:24 AM EDT - CTD Obtains Right of Reference to Alzheimer’s Disease Expanded Access Data
Jul 11, 2019, 11:05 AM EDT
